- Amazon pushes in-house AI coding tool Kiro over competitors’, memo shows Reuters
- Power your startup with 1 year’s worth of Kiro Pro+, now available through AWS Startups Amazon Web Services (AWS)
- In a sea of agents, AWS bets on structured…
Category: 6. Business
-
Amazon pushes in-house AI coding tool Kiro over competitors', memo shows – Reuters
-
AI could replace 3m low-skilled jobs in the UK by 2035, research finds | Artificial intelligence (AI)
Up to 3m low-skilled jobs could disappear in the UK by 2035 because of automation and AI, according to a report by a leading educational research charity.
The jobs most at risk are those in occupations such as trades, machine operations and…
Continue Reading
-
Hyundai Motor Group and Michelin Partner to Accelerate Next-Generation Tire Technologies for Future Mobility
Jihyun Park
pjh85@hyundai.com
Global PR Strategy & Planning · Hyundai Motor CompanyDisclaimer: Hyundai Motor Group believes the information contained herein to be accurate at the time of release. However, the company may…
Continue Reading
-
Stock market today: Live updates
Traders work on the floor of American Stock Exchange (AMEX) at the New York Stock Exchange (NYSE) in New York, US, on Monday, Nov. 24, 2025.
Michael Nagle | Bloomberg | Getty Images
Stock futures are little changed Monday night after major U.S….
Continue Reading
-
Porsche Cayenne Electric makes public debut at Icons of Porsche
1. All information offered on Porsche Newsroom, including but not limited to, texts, images, audio and video documents, are subject to copyright or other legislation for the protection of intellectual property. They are intended…
Continue Reading
-
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Ad hoc announcement pursuant to Art. 53 LR
- Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studies
- One-time dose of Itvisma replaces SMN1…
Continue Reading
- Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studies
-
ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS SECOND QUARTER OF FISCAL YEAR 2026
LAVAL, QC, Nov. 24, 2025 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD) announces its results for its second quarter ended October…
Continue Reading
-
Zoom Communications lifts annual outlook on accelerated demand for AI tools in hybrid work – Reuters
- Zoom Communications lifts annual outlook on accelerated demand for AI tools in hybrid work Reuters
- Zoom Reports Strong Sales in Bright Sign for Expanded Products Bloomberg.com
- Zoom Communications Reports Financial Results for the Third Quarter of…
Continue Reading
-
AMGEN TO PRESENT AT CITI’S 2025 GLOBAL HEALTHCARE CONFERENCE| Amgen
THOUSAND OAKS, Calif. ,Nov. 24, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at Citi’s 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3, 2025. Peter Griffith, executive vice president and chief financial officer…Continue Reading
-
DEFENDER TROPHY: FIRST ENTRANT SELECTED FOR EPIC 2026 ADVENTURE
About The Defender Brand
The Defender Brand embraces the impossible. Each member of the Defender family is purposefully designed, highly desirable and seriously durable. A modern‑day hero that respects the past but at the same time anticipates…Continue Reading